Application 202102

Type
ANDA
Sponsor
ALEMBIC PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ARIPIPRAZOLEARIPIPRAZOLETABLET, ORALLY DISINTEGRATING;ORAL10MGNoYes
002ARIPIPRAZOLEARIPIPRAZOLETABLET, ORALLY DISINTEGRATING;ORAL15MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
13811-692AripiprazoleAripiprazoleTrigen Laboratories, LLCANDACurrent
13811-693AripiprazoleAripiprazoleTrigen Laboratories, LLCANDACurrent
46708-260AripiprazoleAripiprazoleAlembic Pharmaceuticals LimitedANDACurrent
46708-260AripiprazoleAripiprazoleAlembic Pharmaceuticals LimitedANDACurrent
46708-261AripiprazoleAripiprazoleAlembic Pharmaceuticals LimitedANDACurrent
46708-261AripiprazoleAripiprazoleAlembic Pharmaceuticals LimitedANDACurrent
62332-103AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-103AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-103AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-103AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-103AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-103AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-104AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-104AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-104AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-104AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-104AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent
62332-104AripiprazoleAripiprazoleAlembic Pharmaceuticals Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
32179ORIG2015-04-29
19060ORIG2015-04-29